Immusoft is a cell therapy company focused on developing novel therapies for rare diseases using sustained delivery of therapeutic proteins from a patient’s own cells.

Biotechnology

Immusoft

Immusoft's headquarters in Seattle, WA, United States

Sean Ainsworth

David Lowenschuss

Scott McIvor

Rob Hayes

Tony Sun

Peter Sage

Bruce Levine

Michael C. Carroll

Paula Cannon

Robert Sikorski

Hans-Peter Kiem

Cam Gallagher

Matthew Scholz

Julia Moore

The Research and Development team at Immusoft is dedicated to innovating and advancing cell therapy solutions for rare diseases. They focus on designing and conducting experiments to develop sustained delivery systems for therapeutic proteins derived from patients' own cells. This multidisciplinary team collaborates on cutting-edge research to translate scientific discoveries into effective treatments, ensuring safety and efficacy through rigorous testing and validation.

Research and Development

The Leadership Team at Immusoft is responsible for guiding the strategic direction of the company, overseeing research and development initiatives, and ensuring the successful execution of cell therapy projects. With expertise spanning science, development, and executive management, they collaborate to drive innovation in therapeutic solutions for rare diseases and make critical decisions that shape the company's future.

Leadership Team

Immusoft

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

Immusoft

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

Related companies